Cholesterol Absorption Inhibitors

Links shared publicly online about this topic

Support for CETP inhibitors

theheart.org — “A new analysis has found that common variants in the gene coding for cholesterol ester transfer protein have an impact on the future risk of MI and that this association is partly but not fully mediated via effects on baseline HDL-C. The results support continued investigation of agents that target CETP as a potential method for vascular risk reduction, say the researchers. (Ridker PM et al. Circ Cardiovasc Genet; published online before print January 23, 2009.)View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on January 29, 2009 at 8:33 pm By:

theheartorg Shelley Wood Cardiology

Variants at CETP locus affect future risk of MI http://tinyurl.com/cwr44l

3 years ago...

Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - Topix

topix.com — “Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - TopixView full resource at topix.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 7:02 pm By:

carybyrd Cary Byrd - eDrugSearch.com Pharma and Health Advocate

Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study http://t.co/LE9KaWT1

2 months ago...

Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: THOUSAND OAKS, Calif., March 25, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN - News) announced today positive results from a Phase 1b clinical study of AMG 145, an investigational PCSK9 inhibitor, in patients with ...View full resource at finance.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 8:04 pm By:

Cholesterol_OW Cholesterol OW OW Health

Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study: THOUSAND OAKS, Calif., March... http://t.co/0yI7WIR9

2 months ago...

Family Med Medical News about Cholesterol Vegetables Intestinal Absorption

mdlinx.com — “When cholesterol is not cholesterol: A note on the enzymatic determination of its concentration in model systems containing vegetable extractsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 22, 2010 at 6:18 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

When cholesterol is not cholesterol: A note on the enzymatic determination of its concentration in mode... http://bit.ly/bvg9Zd #GM #mdlinx

2 years ago...

Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA

jama.ama-assn.org — “Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMAView full resource at jama.ama-assn.org

  • View Related
  • Share

Most Recently Shared on November 15, 2011 at 1:14 pm By:

JAMA_current JAMA Medical Journal

New medication increases HDL and decreases LDL cholesterol levels. Paper presented at #AHA11 and JAMA publishes online: http://t.co/G7KmRwhu

6 months ago...

Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA

jama.ama-assn.org — “Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMAView full resource at jama.ama-assn.org

  • View Related
  • Share

Most Recently Shared on November 21, 2011 at 4:49 pm By:

Cholesterol Ppt Powerpoint Presentation slides Dr. H S Medical Slideshow inhibit cholesterol absorption sterols displace cholesterol on chylomicron

slideworld.org — “Powerpoint Cholesterol Slides by Dr. H S inhibit cholesterol absorption sterols displace cholesterol on chylomicron Download Free Medical Powerpoint PresentationsView full resource at slideworld.org

  • View Related
  • Share

Most Recently Shared on September 25, 2009 at 6:47 am By:

medicalslides Medical Templates Health Organization

Cholesterol : Cholesterol,high cholesterol,cholesterol diet,low cholesterol,cholesterol foods,cholesterol test,.. http://bit.ly/WyeGj

3 years ago...

Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatch

marketwatch.com — “Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatchView full resource at marketwatch.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 12:15 pm By:

carybyrd Cary Byrd - eDrugSearch.com Pharma and Health Advocate

Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatch http://t.co/JegMV1XV

2 months ago...

New Cholesterol-Lowering Drugs Will Test the Future Healthcare System - Forbes

forbes.com — “The American College of Cardiology (ACC) meeting is in full swing this week in Chicago and much of the early buzz being generated is around a new class of LDL cholesterol-lowering drugs known as proprotein converase subtilisin/kexin type 9 (PCSK-9) antibodies. Inhibitors of PCSK-9 have been pursued for almost a [...]View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 8:07 pm By:

Cholesterol_OW Cholesterol OW OW Health

New Cholesterol-Lowering Drugs Will Test the Future Healthcare System: The American College of Cardiology (ACC) ... http://t.co/p51Irjyi

2 months ago...

New Cholesterol-Lowering Drugs Will Test the Future Healthcare System - Forbes

forbes.com — “The American College of Cardiology (ACC) meeting is in full swing this week in Chicago and much of the early buzz being generated is around a new class of LDL cholesterol-lowering drugs known as proprotein converase subtilisin/kexin type 9 (PCSK-9) antibodies. Inhibitors of PCSK-9 have been pursued for almost a [...]View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 5:52 pm By:

Drugs_Devices Drugs and Devices OW OW Health

New Cholesterol-Lowering Drugs Will Test the Future Healthcare System: The American College of Cardiology ... http://t.co/YvG6SI3g #drug

2 months ago...

The Cholesterol Bet | February 20, 2012 Issue - Vol. 90 Issue 8 | Chemical & Engineering News

cen.acs.org — “The Cholesterol Bet | February 20, 2012 Issue - Vol. 90 Issue 8 | Chemical & Engineering NewsView full resource at cen.acs.org

  • View Related
  • Share

Most Recently Shared on February 20, 2012 at 2:01 pm By:

cenmag C&EN Science Enthusiast

Can firms overcome a huge cholesterol drug flop? by @carmendrahl http://t.co/ysMtp23j $PFE $MRK $LLY $RHHBY

3 months ago...

DEFINE: Large Effects on LDL and HDL Cholesterol With CETP Inhibitor Anacetrapib - QualityPoint Technologies

qualitypointtech.net — “With the dramatic changes in LDL- and HDL-cholesterol levels and no apparent off-target blood pressure, electrolyte, and aldosterone effects, as well as no adverse safety signal that plagued torcetrapib, DEFINE investigators say larger trials with the new CETP inhibitor anacetrapib are justified. HeartwireView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on November 17, 2010 at 9:47 pm By:

MedicalFeed MedicalFeed Health News Feed

DEFINE: Large Effects on LDL and HDL Cholesterol With CETP Inhibitor Anacetrapib: With the dramatic changes in LDL... http://bit.ly/92yCFl

2 years ago...

Study Suggests Possibility that CETP Inhibitors May Improve Glycemic Control - Larry Husten - Cardiobrief - Forbes

blogs.forbes.com — “A new analysis of the ILLUMINATE trial raises the possibility that CETP inhibitors like torcetrapib may have the unexpected beneficial effect of improving glycemic control in addition to their intended effect of raising HDL cholesterol. Development of torceptrapib was halted several years ago following the early termination of the large [...]View full resource at blogs.forbes.com

  • View Related
  • Share

Most Recently Shared on July 18, 2011 at 8:32 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Study Suggests Possibility that CETP Inhibitors May Improve Glycemic Control: A new analysis of the ILL... http://onforb.es/pMKsQI #drug

10 months ago...

Proton Pump Inhibitors on #MDlinx

mdlinx.com — “Proton Pump Inhibitors on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on October 4, 2010 at 7:50 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Association of Long-Term Proton Pump Inhibitor Therapy with Bone Fractures and Effects on Absorption of C... http://bit.ly/dlJlVx #medicine

2 years ago...

Podcast: Overuse of proton pump inhibitors, food allergies, benefit of fibrates, nut consumption/cholesterol levels: http://bit.ly/cPzeos

hopkinsmedicine.org — “Podcast: Overuse of proton pump inhibitors, food allergies, benefit of fibrates, nut consumption/cholesterol levels: http://bit.ly/cPzeosView full resource at hopkinsmedicine.org

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 3:47 pm By:

HopkinsMedNews JohnsHopkinsMedicine Health News

Podcast: Overuse of proton pump inhibitors, food allergies, benefit of fibrates, nut consumption/cholesterol levels: http://bit.ly/cPzeos

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • theheartorg

    Shelley Wood

    Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4

    View Profile

  • carybyrd

    Cary Byrd - eDrugSearch.com

    I run a comparison shopping engine and social network for prescription-drug buyers. We regularly post drug news and money-saving tips on our blog.

    View Profile

  • Cholesterol_OW

    Cholesterol OW

    Organizing cholesterol resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390